It has also been suggested that the model of using biologic agents with molecularly targeted activity in selected cancer cases as in the use of trastuzumab (Herceptin) in HER-2/Neu positive breast cancer could also improve effectiveness of these MMPIs (26). The gene discussed is ERBB2; the disease is breast cancer.